Working together towards better liver health

Welcome!

Our commitment is to provide the right treatment to the right patient at the right time.

This website provides a variety of educational resources and congresses updates for your use and intended for HCPs only.

 

To access the site please login.

You will first need to register if it's your first visit.

Login
Register

Providing the right treatment to the right patient at the right time

The combined treatment of Atezolizumab & Bevacizumab has become the SoC in 1L uHCC

Hepatocellular carcinoma Tecentriq
An HCC case study
Tecentriq Avastin
Clinical results
Hepatocellular carcinoma Oncology
Treatment decision tool
Hepatocellular carcinoma Oncology
An overview

HCC-related Conferences & Congresses updates 

Oncology Hepatocellular carcinoma
Atezo-bev RWD: 550 pts.from 33 French medical centers
Oncology Hepatocellular carcinoma
Symposium slides - Unveiling the key factors: critical aspects in HCC treatment today
Hepatocellular carcinoma Tecentriq
Dr. Lalazr review on HCC updates
Oncology Hepatocellular carcinoma
Symposium slides - Expanding Horizons in HCC Incl. RFS of adjuvant treatment from IMbrave050 trial
Oncology Hepatocellular carcinoma
IMbrave150: HCC pts with VP4
Hepatocellular carcinoma Oncology
Symposium Review

Sharing experience

Hepatocellular Carcinoma with PVTT

Dr. Maria Pashak, Hepatobiliar Oncology, Rambam MC

Hepatocellular Carcinoma driven by NASH

Dr. Ofer Purim, Director of the Gastrointestinal Tumors Service and Dr. Gadi Lalazar, Director of the Gastroenerology Unit, Shaare Zedek Medical center

Treating HCC with QoL and Long Survival

Dr. Ofer Margalit and Prof. Noam Tau, Oncology, Sheba Medical Center

A Third Round of Hepatocellular Carcinoma 

Dr. Maria Pashak, Hepatobiliar Oncology, Rambam MC

Would you like to share your case?
Share your case here!
You are about to leave Roche4Med website. Links to external web pages are offered for your convenience. Roche Pharmaceuticals (Israel) Ltd. is not responsible for the content displayed on those pages.